In California, Green Earth Institute Co. has closed its Series B investment round with an investment agreement from Sustainable Conversion Ventures. GEI is a startup from the Research Institute of Innovative Technology for the Earth (RITE) in 2011 to commercialize bioconversion systems featuring growth-arrested Coryneform bacteria strains that achieve near theoretical maximums of chemical production for amino and organic acids. With its Series B round closed, GEI is gong to market with their first strain of Coryneform producing L-alanine.
Green Earth Institute represents Sustainable Conversion Ventures’ fifth investment agreement in the renewable chemicals and synthetic biology space.
More on the story.
